Abstract:The novel 4‐quinolone‐2‐carboxylic acid derivatives are synthesized and characterized, demonstrating significant antibacterial activity against Gram‐negative bacteria, particularly P. aeruginosa and E. coli. The compound 2‐(1‐(4‐chlorobenzyl)‐4‐oxo‐1,4‐dihydroquinolin‐2‐yl)acetic acid (5a) shows strong binding energy in molecular docking studies against LpxC and PBP3 enzymes, suggesting effective mechanisms of action. Additionally, the derivatives indicate favorable for ADMET profiles, supporting their potential for oral formulations with reduced toxicity. Quinolones represent a class of potent antibacterial agents that primarily function by inhibiting bacterial topoisomerases and DNA gyrase. A crucial feature of their structure is a carboxylic acid group at the C‐3 position, which facilitates interaction with the active sites of these enzymes. Since the mid‐20th century, the emergence and proliferation of antimicrobial resistance (AMR) have posed significant challenges in society, necessitating the development of novel therapeutic agents. In this context, a new series of quinolone derivatives has been designed and synthesized based on transtorine. All synthesized compounds were tested against both Gram‐positive and Gram‐negative bacteria, as well as three fungal strains. Among the new compounds, 5a, 5d, and 5f demonstrated superior activity against Gram‐negative bacteria, with 5a showing notable effectiveness against P. aeruginosa compared to ciprofloxacin and norfloxacin. However, none of the compounds exhibited activity against fungal strains. Molecular docking studies revealed that compound 5a inhibited five bacterial proteins, primarily targeting bacterial cell wall synthesis. Additionally, ADMET parameters indicated that the promising compounds are suitable for oral administration with limited penetration across the blood–brain barrier compared to existing standards. This research indicates a potential pathway for developing new quinolone‐based antibiotics in the fight against AMR.

Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximes

Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives

Synthesis of Substituted Arylidene Hydrazinyl Trifluoromethyl Thiazole Derivatives and their Antibacterial Studies using different Genes Expression

Synthesis, Structure and Antibacterial Activity of Novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone Oxime Ester Derivatives

Synthesis, Characterization, and Biological Evaluation of Novel 7-Oxo-7H-thiazolo[3,2-b]-1,2,4-triazine-2-carboxylic Acid Derivatives

Unique Carbazole-Oxadiazole Derivatives as New Potential Antibiotics for Combating Gram-Positive and -Negative Bacteria

Synthesis and Antibacterial Evaluation of Novel Clarithromycin Derivatives with C-4″ Elongated Arylalkyl Groups Against Macrolide-Resistant Strains.

Design, Synthesis, and Molecular Docking Analysis of 4‐Quinolone‐2‐Carboxylic Acid Derivatives as Antimicrobial Agents

Novel 2-(benzo[d]thiazol-2-yl)-1-(3-methyl-5-substituted-phenyl-4,5- dihydropyrazol-1-yl)ethanone Derivatives: Synthesis and antibacterial activity

Synthesis, Characterization and Biological Activity Evaluation of Novel Quinoline Derivatives as Antibacterial Drug

Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives

Towards new bioactive fluorine-containing 1,3,4-oxadiazole-amide derivatives: synthesis, antibacterial activity, molecular docking and molecular dynamics simulation study

Synthesis and Biological Evaluation of Halogenated 2-Arylimino-3-arythiazolidine- 4-Ones Containing Benzoic Acid Fragments As Antibacterial Agents

Synthesis, Biological Evaluation and In Silico Studies of Oxime Ether Derivatives Containing a Quinoxaline Moiety

Novel biologically active pyridine derivatives: Synthesis, structure characterization, in vitro antimicrobial evaluation and structure-activity relationship

SYNTHESIS, MOLECULAR BIOINFORMATICS MODELLING, AND ANTIMICROBIAL EVALUATION OF SOME NOVEL OXADIAZOLE FLUOROQUINOLONE DERIVATIVES

Synthesis And Antibacterial Activities Of 2-(1-Aryl-5-Methyl-1,2,3-Triazol-4-Yl)-1,3,4-Oxadiazole Derivatives

Novel 4-Bromo-2-(3-methyl-1-(substituted-phenylsulfonyl)-4,5-dihydro-1- H-pyrazol-5-yl)phenol Derivatives: Synthesis and Antibacterial Activity

Synthesis and Antimicrobial Activity of 3-Alkylidene-2-Indolone Derivatives

Synthesis, Characterization and Antibacterial Activity of New 5-Aryl Pyrazole Oxime Ester Derivatives

Synthesis and Antibacterial Activity of 3-(3-methoxyphenyl)-2-methylsulfanyl-3Hquinazolin-4-one (4) and 3-(3-methoxyphenyl)-2-thioxo-2,3-dihydro1H-quinazolin-4-one (3) Via N-(3- methoxyphenyl)-methyl dithiocarbamic acid (2)